Obstetrics and Gynecology
monophasic pills are further subdivided into low dose (if the amount of ethinyl estradiol is <
0.05 mg) and standard dose (the amount of ethinyl estradiol is 0.05 mg). The commonly
used progestins are levonorgestrel, norethisterone and lynosterol. The estrogens are either
ethinyl estradiol or menstranol.
The mechanism of action of OCPs is mainly by inhibition of ovulation but thickening of
cervical mucus, decidualization of the endometrium and alteration of motility of the fallopian
tubes also contribute.
The absolute contraindications are proven or suspected pregnancy, undiagnosed abnormal
uterine bleeding, coronary artery disease, history of stroke or thromboembolism, active liver
disease, liver adenoma, estrogen dependent neoplasm, breast cancer, and smoking over the
age of 35 years. The relative contraindications are breast feeding, migraine headache,
history of cholestasis, severe hypertension, diabetes mellitus, varicose veins and elective
operation in 4 weeks. Epilepsy, and anti Tb treatment are relative contraindications because
of accelerated clearance of the hormones.
The side effects are nausea, vomiting, weight gain, headache, breast soreness, acne,
chloasma, and mild hirsutism, mood changes like depression, break through bleeding, post
pill amenorrhea, leucorrhea, vaginal candidiasis, headache and decreased amount of breast
milk.
The complications which occur in those with risk factors are vascular thrombosis and
embolism, myocardial infarction, stroke, hypertension, liver tumors especially hepatic
adenoma and cholelithiasis.
The danger symptoms that indicate discontinuation are severe migraine, visual disturbance,
sudden chest pain, severe cramps and swelling of the legs, severe right upper quadrant pain
or jaundice and breast lump.
Additional indications for discontinuation are excessive weight gain, client wish to conceive,
client request and planned elective surgery.
Non contraceptive benefits of OCPs are relief of menorrhagia, relief of dysmenorrhea, relief
of dysfunctional uterine bleeding and premenstrual syndrome, improvement of iron deficiency
anemia and endometriosis. It is also associated with marked reduction in the risk of pelvic
inflammatory disease (protective thick cervical mucus), benign breast disease, fibroid uterus,
carcinoma of the endometrium, carcinoma of the ovary and osteoporosis.
2. Progestin only pill (Minipill or POP)
These pills contain only progesterone derivatives in very low dose. The progestins commonly
used are levonorgestrel 75 mg, norethisterone 350 mg, ethinodiol diacetate 500 mg,
249